MYR Pharmaceuticals has incorporated its first European subsidiary in France
BAD HOMBURG, Germany, June 10, 2020 /PRNewswire/ — MYR Pharmaceuticals, a German biotechnology company focused on the development and commercialization of therapeutics for the treatment of chronic hepatitis B and D, is pleased to announce the establishment of its wholly owned subsidiary…
Comments Off on MYR Pharmaceuticals has incorporated its first European subsidiary in France